Invest in VADE Nutrition. A Billion Dollar Opportunity
VADE Nutrition is redefining the nutritional supplement industry by making nutrition convenient & portable with pre-measured servings, wrapped in a dissolvable food-grade film.
REASONS TO INVEST
- ✔ VADE Nutrition has $20M+ in revenue, maintaining a growth rate of 1,523% over a 3-year period. Also, a 2-time winner of the Inc 500 Fastest Growing Companies & ranked in the top 12 for all health companies.
- ✔ VADE’s e-commerce success led to space in 8,000+ retail locations in some of the nation’s largest retailers – GNC, Hy-Vee, CVS & more. We’ve also secured multi-million dollar licensing deals & global distributors.
- ✔ Our founder, Joe Johnson, landed a deal on ABC’s Shark Tank & was listed as Forbes 30 Under 30 in 2022. Our products are viral by nature, backing up our 500M+ impressions on social media & 8,000+ 5-Star reviews.
VADE Nutrition was formed on a mission to redefine the nutritional supplement industry by making nutrition convenient & portable with pre-measured servings, wrapped in a dissolvable food-grade film. On our path to achieve this mission, we’ve been fortunate to have experienced unparalleled growth and accomplishments that most could only dream of. From $17,000 in sales a few years ago, to now over $20M in lifetime revenue, maintaining a growth rate of 1,523% over a 3-year period, & a 2-time winner of the Inc 500 Fastest Growing Companies in America. Ranked in the top 12 for all health companies. Landing deals with top retailers like GNC, Hy-Vee, and CVS led to us having space in over 8,000 retail locations across the country. Jumpstarted by our successful appearance on ABC’s Shark Tank, we’ve generated over 500M views across social media platforms. These successes spurred on being listed in the prestigious Forbes 30 Under 30 list.
Investment Terms
- ✔ Size of Round: Up to $10M
- ✔ Pre-Money Valuation: $18.5M
- ✔ Estimated 2028 Revenue: $181.6M
VADE Nutrition is Filing an Assignment for the Benefit of Creditors
With our successes as the backdrop, the struggles and challenges we’ve faced over the last few years have also been seemingly unparalleled. In 2022 VADE Nutrition hit the highest growth with a gross revenue of $6.1M, though in 2023 and 2024 VADE Nutrition experienced a revenue reduction. This decline was due to a combination of factors including a substantial rise in our cost of goods sold due to supply chain constraints, a strategic pivot towards optimizing operations for long-term profitability, and unforeseen delays in our supply chain. The greatest factor of the extended downturn has been taking the manufacturing in-house and the loss of our co-packing partnership, making it impossible to produce any products until our in-house manufacturing is fully functional.
Despite these challenges, VADE Nutrition remains uniquely positioned for an exciting future. By taking control of our manufacturing in-house, we are not just overcoming obstacles but actively building a stronger, more scalable business. This strategic move enables us to optimize quality, reduce costs, and gain full oversight of our production process, which will foster long-term profitability. While the temporary setback of losing our co-packing partnership and the supply delays were tough, they have opened the door to immense growth potential. We are now moving forward with a clear path towards a brighter future—one that includes filing an Assignment for the Benefit of Creditors (ABC) to reset the business and eliminate legacy liabilities. This process offers a unique opportunity for investors to secure high-value assets at an attractive price, ensuring the foundation for accelerated growth and success in the years ahead.
Estimated Purchase Price of Full Asset Package: $615K - $1.27M – Offering substantial upside for investors by acquiring high-value assets at a fraction of their market valuation.
View full Asset Package Summary
